This inventor holds 8 USPTO granted patents and 5 published patent applications. Top assignee: The University of British Columbia. Active years: 2015-2019.
Location History:
- Vancouver, CA (2015 - 2019)
- Seattle, WA (US) (2017 - 2019)
Company Filing History:
Years Active: 2015-2019
Title: The Innovative Contributions of Charles De Leeuw
Introduction
Charles De Leeuw is a prominent inventor based in Seattle, WA (US). He has made significant contributions to the field of biotechnology, holding a total of 8 patents. His work primarily focuses on the development of mini-promoters that have various applications in gene therapy and cellular expression.
Latest Patents
Among his latest patents, the OLIG1 mini-promoter stands out. This invention involves isolated polynucleotides that comprise an OLIG1 mini-promoter, which can be operably linked to expressible sequences such as reporter genes and regulatory RNA sequences. The applications of this mini-promoter include methods for expressing sequences of interest, which can be utilized for identifying or labeling cells, monitoring cellular expression, and gene therapy. Another notable patent is the CLDN5 mini-promoter, which also consists of isolated polynucleotides. Similar to the OLIG1 mini-promoter, it can be linked to expressible sequences and is designed for use in methods of expressing sequences of interest.
Career Highlights
Charles De Leeuw is affiliated with the University of British Columbia, where he continues to advance his research and innovations. His work has garnered attention in the scientific community, contributing to the understanding and application of gene expression technologies.
Collaborations
Throughout his career, De Leeuw has collaborated with notable colleagues such as Wyeth W Wasserman and Daniel Goldowitz. These collaborations have further enriched his research and expanded the impact of his inventions.
Conclusion
Charles De Leeuw's innovative work in the field of biotechnology, particularly in the development of mini-promoters, showcases his significant contributions to science and medicine. His patents reflect a commitment to advancing gene therapy and cellular research, making him a noteworthy figure in the realm of inventors.